Allergic Diseases in Nephrotic ChildrenPBAAR-NSNCT07896291
Prevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University Hospital
An observational study of Allergic Diseases in Nephrotic Children and Nephrotic Syndrom, run by Sohag University at 1 site in Egypt.
Trial summary
This is a study at sohag university hospital aim to determine the precelance of Bronchial Asthma and Allergic Rhinitis among children with Nephrotic Syndrom Read more about this study
- Who is it for?
- Ages 2 to 18 years
- Conditions the study is for
- Allergic Diseases in Nephrotic Children, Nephrotic Syndrom
- How many people
- 20 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Nov 2026to 1 Apr 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Children diagnosed with nephrotic syndron Aged 2 to 18 year attending at sohag university hospital
Who may be able to join
None listed.
Who cannot join
- children below 2 years
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Sohag university hospital
Sohag
Samah Khaled Elsaman, Pediatric resident, 01011262937, Samah.Khaled@med.sohag.edu.eg
About this study
This is a study at sohag university hospital aim to determine the precelance of Bronchial Asthma and Allergic Rhinitis among children with Nephrotic Syndrom
Read the detailed description
This study aims to determine the prevalence of bronchial asthma and allergic rhinitis among children with nephrotic syndrome attending Sohag University Hospital. The study will assess the occurrence of these allergic conditions in children aged 2-18 years and explore their clinical characteristics and possible associations with nephrotic syndrome. The findings may help improve the recognition and management of allergic diseases in children with nephrotic syndrome.
- Keywords
- Nephrotic Syndrom, Allergic Rhinitis and Bronchial Asthma
- Medical subject headings
- Rhinitis, Allergic, Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Children aged from 2 to 18 years old ,diagnosed with Nephrotic Syndrom | No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevelance of Bronchial Asthma and Allergic Rhinitis among Children with Nephrotic Syndrom at Sohag University Hospital
Prevelance of Bronchial Asthma and Allergic Rhinitis among Children with Nephrotic Syndrom at Sohag University Hospital
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2026
- Study start1 Nov 2026 (estimated)
- Primary completion1 Mar 2027 (estimated)
- Study completion1 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Allergic Diseases in Nephrotic ChildrenStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Samah Khaled Elsaman, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07896291
- Sponsor's protocol ID
- Soh-Med-26-9-13MS
- Acronym
- PBAAR-NS
- Status last verified
- Oct 2026
- First submitted
- 20 Oct 2026
- Last updated
- 27 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Indivisuals participants data will not be shared due to privacy protection policies at sohag university hospital
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevelance of Bronchial Asthma and Allergic Rhinitis Among Children With Nephrotic Syndrom at Sohag University Hospital
- ClinicalTrials.gov ID
- NCT07896291
- Acronym / sponsor ID
- PBAAR-NS / Soh-Med-26-9-13MS
- Keywords
- Nephrotic Syndrom, Allergic Rhinitis and Bronchial Asthma
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Nov 2026 (estimated)
- Primary completion
- 1 Mar 2027 (estimated)
- Study completion
- 1 Apr 2027 (estimated)
- First posted
- 26 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a study at sohag university hospital aim to determine the precelance of Bronchial Asthma and Allergic Rhinitis among children with Nephrotic Syndrom
Detailed description
This study aims to determine the prevalence of bronchial asthma and allergic rhinitis among children with nephrotic syndrome attending Sohag University Hospital. The study will assess the occurrence of these allergic conditions in children aged 2-18 years and explore their clinical characteristics and possible associations with nephrotic syndrome. The findings may help improve the recognition and management of allergic diseases in children with nephrotic syndrome.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Children aged from 2 to 18 years old ,diagnosed with Nephrotic Syndrom | – | –No intervention |
Who may qualify
- Ages
- 2 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Children diagnosed with nephrotic syndron Aged 2 to 18 year attending at sohag university hospital
Key inclusion criteria (0 listed)
Key exclusion criteria (1 listed)
- children below 2 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevelance of Bronchial Asthma and Allergic Rhinitis among Children with Nephrotic Syndrom at Sohag University Hospital
Time frame: 6 months
Prevelance of Bronchial Asthma and Allergic Rhinitis among Children with Nephrotic Syndrom at Sohag University Hospital
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2026.
- Individual participant dataSharing planned: No. Indivisuals participants data will not be shared due to privacy protection policies at sohag university hospital
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Allergic Diseases in Nephrotic Children and Nephrotic Syndrom, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Samah Khaled Elsaman (01011262937, Samah.Khaled@med.sohag.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevelance of Bronchial Asthma and Allergic Rhinitis among Children with Nephrotic Syndrom at Sohag University Hospital (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.